MYELODYSPLASTIC DISORDERS
Clinical trials for MYELODYSPLASTIC DISORDERS explained in plain language.
Never miss a new study
Get alerted when new MYELODYSPLASTIC DISORDERS trials appear
Sign up with your email to follow new studies for MYELODYSPLASTIC DISORDERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cancer diagnostic tool could change how doctors choose treatments
Diagnosis Recruiting nowThis study is testing a new platform that uses advanced testing to get a complete picture of a person's tumor. The goal is to see if this detailed information can help doctors choose better treatments for patients with high-risk cancers like leukemia, multiple myeloma, and pancre…
Matched conditions: MYELODYSPLASTIC DISORDERS
Phase: NA • Sponsor: Azienda Ospedaliero-Universitaria di Parma • Aim: Diagnosis
Last updated Jun 27, 2026 09:05 UTC
-
Scientists map genetic secrets of blood cancers to find new treatments
Knowledge-focused Recruiting nowThis study collects and analyzes genetic and molecular data from 250 people with various blood cancers, including leukemia and lymphoma. Researchers will test cancer cells in the lab with many drugs to see which ones work best. The goal is to match genetic features with drug resp…
Matched conditions: MYELODYSPLASTIC DISORDERS
Phase: NA • Sponsor: Azienda Ospedaliero-Universitaria di Parma • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
Blood cancer atlas: 1,000-Patient study hopes to personalize treatment
Knowledge-focused Recruiting nowThis study is collecting bone marrow, blood, and tissue samples from over 1,000 people with various blood cancers. Researchers will use advanced genetic and protein analysis to identify unique markers for each cancer type. They will also test cancer cells against a library of 300…
Matched conditions: MYELODYSPLASTIC DISORDERS
Phase: NA • Sponsor: Azienda Ospedaliero-Universitaria di Parma • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC